KY HB308 | 2017 | Regular Session
Status
Spectrum: Partisan Bill (Republican 3-0)
Status: Engrossed on March 8 2017 - 50% progression, died in committee
Action: 2017-03-29 - 2nd reading, to Rules
Pending: Senate Rules Committee
Text: Latest bill text (Draft #2) [PDF]
Status: Engrossed on March 8 2017 - 50% progression, died in committee
Action: 2017-03-29 - 2nd reading, to Rules
Pending: Senate Rules Committee
Text: Latest bill text (Draft #2) [PDF]
Summary
Create a new section of KRS Chapter 217 to define terms; prohibit substitution or dispensing of an equivalent drug product without documentation from a prescribing health care practitioner; create a new section of Subtitle 17A of KRS Chapter 304 to define terms and limit cost sharing for generic abuse-deterrent opioid analgesic drug products; create a new section of KRS Chapter 205 to permit Medicaid compliance.
Title
AN ACT relating to abuse-deterrent opioid analgesic drug products.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-03-29 | Senate | 2nd reading, to Rules |
| 2017-03-15 | Senate | reported favorably, 1st reading, to Calendar with Committee Substitute and committee amendment (1-title) |
| 2017-03-08 | Senate | to Health & Welfare (S) |
| 2017-03-08 | Senate | received in Senate |
| 2017-03-07 | House | 3rd reading, passed 85-1 with Committee Substitute (1) |
| 2017-03-06 | House | posted for passage in the Regular Orders of the Day for Tuesday, March 7, 2017 |
| 2017-03-03 | House | 2nd reading, to Rules |
| 2017-03-02 | House | reported favorably, 1st reading, to Calendar with Committee Substitute |
| 2017-03-01 | House | posted in committee |
| 2017-02-14 | House | to Health and Family Services (H) |
| 2017-02-10 | House | introduced in House |
